Irbesartan reduces cardiovascular risk in hypertensive diabetic and non-diabetic subjects independent of BMI
โ Scribed by Fernando De Alvaro; Jesus Honorato; Carlos Calvo; Claudia Filozof; Olga Velasco; Miguel A. Sanchez; Inma Parrondo
- Book ID
- 116209017
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 106 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0895-7061
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Circulating concentrations of total cholesterol, triglycerides, non-esterified fatty acids (NEFA), glycerol, and 3-hydroxybutyrate (3-HB) were measured in 133 subjects with normal glucose tolerance (NGT), 78 with impaired-glucose-tolerance (IGT) and 189 noninsulin dependent (Type 2) diabetic (NIDDM)
## Background: A possible association of glycemia with arterial hypertension has been suggested by the frequent co-occurrence of impaired glucose tolerance or type 2 diabetes mellitus with arterial hypertension. the objective was to examine the relationship of glycated hemoglobin (hba1c) concentrat